Aerovate Therapeutics (AVTE) Insider Trading & Ownership $2.61 -0.05 (-1.88%) (As of 11/21/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aerovate Therapeutics (NASDAQ:AVTE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$3.92 M Get AVTE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aerovate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVTE Insider Buying and Selling by Quarter Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Aerovate Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/14/2024George A EldridgeInsiderSell15,000$25.03$375,450.00 5/17/2024Hunter GilliesInsiderSell4,000$21.08$84,320.00 5/16/2024Timothy P. NoyesCEOSell10,000$21.58$215,800.00 5/2/2024Marinus VerwijsInsiderSell1,981$21.02$41,640.62 5/1/2024Timothy P. NoyesCEOSell11,357$20.34$231,001.38 4/17/2024Benjamin T DakeInsiderSell6,853$22.37$153,301.61 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/16/2024Timothy P. NoyesCEOSell10,000$24.70$247,000.00 4/10/2024George A EldridgeInsiderSell7,500$26.85$201,375.00 4/9/2024David S GrayzelDirectorSell11,882$28.15$334,478.30 4/1/2024Benjamin T DakeInsiderSell3,325$31.97$106,300.25 4/1/2024Timothy P. NoyesCEOSell10,000$30.00$300,000.00 3/27/2024Benjamin T DakeInsiderSell11,068$27.97$309,571.96 3/25/2024Benjamin T DakeInsiderSell3,432$28.01$96,130.32 3/19/2024Marinus VerwijsinsiderSell5,300$26.08$138,224.00 3/13/2024George A EldridgeInsiderSell2,016$25.02$50,440.32 3/11/2024George A EldridgeInsiderSell3,433$25.25$86,683.25 3/8/2024George A EldridgeInsiderSell114$25.00$2,850.00 2/23/2024Hunter GilliesInsiderSell511$19.50$9,964.50 2/20/2024Hunter GilliesInsiderSell3,489$20.23$70,582.47 2/5/2024Ralph NivenInsiderSell4,600$17.45$80,270.00 1/17/2024Hunter GilliesInsiderSell4,000$19.50$78,000.00 1/5/2024Ralph NivenInsiderSell4,600$19.16$88,136.00 12/27/2023Hunter GilliesInsiderSell125$24.50$3,062.50 12/20/2023Hunter GilliesInsiderSell4,000$19.50$78,000.00 12/13/2023Hunter GilliesInsiderSell2,103$19.50$41,008.50 12/5/2023Ralph NivenInsiderSell4,600$16.30$74,980.00 11/27/2023Benjamin T DakeInsiderSell12,517$16.24$203,276.08 11/24/2023Benjamin T DakeInsiderSell4,990$15.74$78,542.60 11/22/2023Benjamin T DakeInsiderSell9,382$15.17$142,324.94 (Data available from 1/1/2013 forward) AVTE Insider Trading Activity - Frequently Asked Questions Who is on Aerovate Therapeutics's Insider Roster? The list of insiders at Aerovate Therapeutics includes Benjamin T Dake, David S Grayzel, George A Eldridge, Hunter Gillies, Marinus Verwijs, Ralph Niven, Timothy P Noyes. Learn more on insiders at AVTE. What percentage of Aerovate Therapeutics stock is owned by insiders? 24.90% of Aerovate Therapeutics stock is owned by insiders. Learn more on AVTE's insider holdings. Which Aerovate Therapeutics insiders have been selling company stock? The following insiders have sold AVTE shares in the last 24 months: Benjamin T Dake ($1,703,746.76), David S Grayzel ($334,478.30), George A Eldridge ($1,329,568.51), Hunter Gillies ($465,558.57), Marinus Verwijs ($205,790.43), Ralph Niven ($366,033.50), and Timothy P Noyes ($309,150.00). How much insider selling is happening at Aerovate Therapeutics? Insiders have sold a total of 396,175 Aerovate Therapeutics shares in the last 24 months for a total of $8,695,149.36 sold. Aerovate Therapeutics Key ExecutivesMr. Timothy P. Noyes M.B.A. (Age 62)CEO & Director Compensation: $936.9kMr. George A. Eldridge (Age 61)CFO & Treasurer Compensation: $658.6k1 recent tradesMr. Timothy J. Pigot (Age 53)Chief Commercial Officer Compensation: $584.6kDr. Benjamin T. Dake Ph.D. (Age 48)Founder, President, COO & Secretary Compensation: $435.5kDr. Marinus Verwijs Ph.D. (Age 48)Chief Technical Officer Compensation: $439.88kDr. Ralph W. Niven M.B.A. (Age 64)M.R, Ph.D., Pharm.S, Chief Scientific Officer Compensation: $372.33kMr. Hunter Gillies M.D. (Age 58)Chief Medical Officer Compensation: $512.74kMs. Donna DeaHead of Regulatory AffairsMs. Susan FischerExecutive Vice President of Development OperationsMr. Stephen K. YuSenior Vice President of Quality More Insider Trading Tools from MarketBeat Related Companies CytomX Therapeutics Insider Trading Immunic Insider Trading Gossamer Bio Insider Trading iTeos Therapeutics Insider Trading Sage Therapeutics Insider Trading Voyager Therapeutics Insider Trading uniQure Insider Trading C4 Therapeutics Insider Trading Rezolute Insider Trading Eton Pharmaceuticals Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:AVTE) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredAmerica’s Pro-Crypto AgendaCash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Crypto 101 Media | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
